Personal tools
You are here: Home Consortium
Navigation
Log in


Forgot your password?
 
Document Actions

Consortium

by odebardo last modified 01-09-2008 11:55

 

Partner

Short name

Scientist's name

Role in the project

1

RKI

ELLERBROK Heinz

Email : EllerbrokH@rki.de

In addition to overall coordination of the project, RKI and optimizes purification protocols and develops molecular diagnostics systems for single and multiple virus and bacteria detection.

2

ICL

BRAY Dorothy

Email : dorothy.bray@immunoclin.com

ImmunoClin provides scientific and technical coordination of overall program as well as leading clinical validation and assessment of applicability of the multiple virus detection diagnostic tools in patient samples. Sensitivity, specificity, ease to use and costs of novel diagnostic tools will be assessed.

3

ApoH technologies

Stefas Ilias

Email : ilias.stefas@wanadoo.fr

ApoH-Technologies focus on infectious disease research that has led to the development of an original product covering the diagnosis area of infectious diseases.ApoH Technologies is developing ApoH coated supports and also purifying ApoH isoforms to improve virus capture.

4

IRD

VEAS Fancisco

Email : Francisco.Veas@mpl.ird.fr

The research unit “Viral Emerging Diseases” has three laboratories respectively located in France (Montpellier), Thailand (Bangkok, Salaya), and Gabon (CIRMF, Libreville). IRD is developing strategy of virus capture and testing infectivity of ApoH captured viruses.

5

PUCCH

LOPEZ Marcelo

Email : malopez@med.puc.cl

The team led by Dr. López-Lastra has sound expertise to handle clinical and molecular aspects of the different level 3 viruses included in this project. They are developing high throughput screening assays for Andes Hantavirus and initiated similar studies on HCV.

6

GenExpress

Kaiser Marco

Email : info@genexpress.de

Development and optimization of PCR assays necessary for partners, to detect pathogens. Generation, purification and distribution of specific probes for detection of pathogens in arrays.

7

ISIT

Elsholz Bruno

Email : elsholz@isit.fhg.de

ISIT supplies the eBiochip detection technology, develops and manufactures the electrical microarrays, including the adaptation of the bio interface to new applications according to the needs of the project partners, especially for the scientific link to all applications and the detection procedures.

8

eBiochips

Wörl Ralf

Email : woerl@ebiochip.com

eBiochips is developing assays for Dengue 1,2,3 and 4 viruses aiming to provide a tool capable of detecting multiple viruses in one biochip.

9

SKULDTECH

Ritter Didier

Email : info@skuldtech.com

While ApoH technology will coat magnetic beads in a pretreatment step to improve the threshold of detection of emerging disease viruses increasing the sensitivity of the technique specifically developed for diagnosis, Skuld-Tech Mini-Array methodology aims to reveal ApoH binding virus through higher sensitivity, high specificity, greater efficiency and reliability, easy to use, and straightforward interpretation, and low costs. Skuld-Tech realizes all the steps involving in design and development or adaptation of multiple detection Mini-array method based on detection that combines target nucleic acid amplification by PCR and specific hybridisation using enzyme-linked antibodies that produce a dark-blue precipitate on a nylon membrane.
« February 2012 »
Su Mo Tu We Th Fr Sa
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29